Is the combination between beta-blockers and calcium antagonists appropriate in the management of angina pectoris?
Godfraind
T
T
Laboratoire de Pharmacodynamie Générale et de Pharmacologie, Université Catholique de Louvain, Belgium.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D015737:Nisoldipine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D015737:Nisoldipine